References
- Hirsh J. Use of warfarin (coumarin). Heart Dis Stroke 1993; 2(3): 209–16
- Brigden ML. Oral anticoagulant therapy: newer indications and an improved method of monitoring. Postgrad Med 1992; 91(2): 285–96
- Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 1993; 95(3): 315–28
- Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation: a multicenter study. Ann Intern Med 1993; 118(7): 511–20
- Lancaster TR, Singer DE, Sheehan MA, et al. The impact of long-term warfarin therapy on quality of life: evidence from a randomized trial. Arch Intern Med 1991; 151(10): 1944–9
- Le DT, Weibert RT, Sevilla BK, et al. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods. Ann Intern Med 1994; 120(7): 552–8
- van der Meer FJ, Rosendaal FR, Vandenbroucke JP, et al. Bleeding complications in oral anticoagulant therapy: an analysis of risk factors. Arch Intern Med 1993; 153(13): 1557–62
- Hull R, Hirsh J, Jay R, et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med 1982; 307(27): 1676–81
- Turpie AG, Gunstensen J, Hirsh J, et al. Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement. Lancet 1988; 1(8597): 1242–5
- Saour JN, Sieck JO, Mamo LA, et al. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990; 322(7): 428–32
- Altman R, Rouvier J, Gurfinkel E, et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 1991; 101(3): 427–31
- Kumar S, Haigh JR, Rhodes LE, et al. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost 1989; 62(2): 729–32
- Richton-Hewett S, Foster E, Apstein CS, et al. Medical and economic consequences of a blinded oral anticoagulant brand change at a municipal hospital. Arch Intern Med 1988; 148(4): 806–8
- Pedersen FM, Hamberg O, Hess K, et al. The effect of dietary vitamin K on warfarin-induced anticoagulation. J Intern Med 1991; 229(6): 517–20
- Chow WH, Chow TC, Tse TM, et al. Anticoagulation instability with life-threatening complication after dietary modification. Postgrad Med J 1990; 66(780): 855–7
- Goodnight SH, Coull BM, McAnulty JH, et al. Antiplatelet therapy. Part II. West J Med 1993; 158(5): 506–14
- Turpie AG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993; 329(8): 524–9
- Gurwitz JH, Avorn J, Ross-Degnan D, et al. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med 1992; 116(11): 901–4
- Schuster GA, Lewis GA. Clinical significance of hematuria in patients on anticoagulant therapy. J Urology 1987; 137(5): 923–5
- Wilcox CM, Truss CD. Gastrointestinal bleeding in patients receiving long-term anticoagulant therapy. Am J Med 1988; 84(4): 683–90